Abiopharma

🔍 Kenny John P. (Director)

Company: NEOGENOMICS INC (NEO)

Report Date: 2026-01-01

Detailed Transactions and Holdings:

• Acquired 4,171 shares of Stock Option (Right to Buy) at $11.76 per share (Derivative)
  Date: 2026-01-01 | Code: A | Expires: 2036-01-01 | Exercise: 2026-06-01 | equity_swap_involved: 0 | shares_owned_after: 4,171.00 | transaction_form_type: 4
• Acquired 5,893 shares of Restricted Stock Unit (Derivative)
  Date: 2026-01-01 | Code: A | Exercise: 2026-06-01 | equity_swap_involved: 0 | shares_owned_after: 5,893.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Once vested, the shares of common stock are not subject to expiration.